Genmark Diagnostics reported $94.2M in Equity Capital and Reserves for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Accelerate Diagnostics AXDX:US -69750000 3.39M
Agilent A:US $ 4946M 136M
Bruker BRKR:US $ 1015.4M 47.7M
Danaher DHR:US $ 42756M 2337M
Exact Sciences EXAS:US $ 3559.1M 89.89M
Genmark Diagnostics GNMK:US $ 94.2M 0.24M
Hologic HOLX:US $ 3877.1M 82.7M
Illumina ILMN:US $ 5180M 258M
Laboratory Of America LH:US $ 10245.1M 223.6M
Luminex LMNX:US $ 488.05M 29.66M
Mesa Laboratories MLAB:US $ 399M 7.22M
Myriad Genetics MYGN:US $ 902.5M 27.3M
Nanostring Technologies NSTG:US $ 219.73M 16.66M
Orasure Technologies OSUR:US $ 404.82M 1.27M
Oxford Immunotec Global OXFD:US $ 191.26M 2.37M
Pacific Biosciences Of California PACB:US $ 258.24M 22.31M
Perkinelmer PKI:US $ 4239.81M 237.5M
Quest Diagnostics DGX:US $ 5899M 846M
Quidel QDEL:US $ 1411.08M 78.64M
Siemens SIE:GR € 42075M 1949M
Thermo Fisher Scientific TMO:US $ 36854M 1796M
Veracyte VCYT:US $ 971.18M 3.05M
Waters WAT:US $ 268.27M 37.31M